GWMR
TAK icon

GC Wealth Management RIA’s Takeda Pharmaceutical TAK Stock Holding History

GC Wealth Management RIA’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,856
Closed -$159K – 811
2025
Q3 		$159K Buy
+10,856
New +$161K 0.01% 831
2024
Q4 		– Sell
-26,171
Closed -$372K – 316
2024
Q3 		$372K Buy
26,171
+4,468
+21% +$63.4K 0.07% 226
2024
Q2 		$281K Buy
21,703
+841
+4% +$11.1K 0.06% 234
2024
Q1 		$290K Buy
20,862
+4,508
+28% +$65.6K 0.06% 229
2023
Q4 		$233K Buy
+16,354
New +$232K 0.11% 193

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GC Wealth Management RIA's TAK Position: Q4 2025 in Review

GC Wealth Management RIA sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 10,856 shares — an estimated $159K sold.

GC Wealth Management RIA first reported a position in TAK in Q4 2023 and held it in 5 quarters. The position peaked at $372K in Q3 2024. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • GC Wealth Management RIA reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • GC Wealth Management RIA sold 10,856 Takeda Pharmaceutical shares in Q4 2025, an estimated $159K.
  • GC Wealth Management RIA first reported a position in Takeda Pharmaceutical in Q4 2023 and held it in 5 quarters.
  • GC Wealth Management RIA's Takeda Pharmaceutical position peaked at $372K in Q3 2024.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.